Skip to content

Breathe 2 Project 3: Comprehensive Chronic Care

Breathe 2 Project 3: Comprehensive Chronic Care

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05382221
Enrollment
979
Registered
2022-05-19
Start date
2022-08-08
Completion date
2025-09-25
Last updated
2025-12-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Smoking Abstinence, Smoking Cessation

Keywords

Chronic Care Tobacco Treatment, Standard of Care, Reduction Treatment, Motivation Phase Treatment

Brief summary

This study will evaluate Comprehensive Chronic Care (CCC), a healthcare treatment approach designed to increase smoking treatment engagement and abstinence among primary care patients who smoke. This research will compare CCC with Standard of Care (SC) on the following outcomes: abstinence at 18 months (primary outcome), treatment reach, and cost-effectiveness. Participation in the study will last 18 months.

Detailed description

This project is a 2-arm randomized controlled trial (RCT) designed to evaluate whether Comprehensive Chronic Care (CCC), relative to Standard Care (SC), increases smoking abstinence and treatment use in primary care patients who smoke. The aims are as follows: * Primary Aim * Aim 1: To determine whether Comprehensive Chronic Care (CCC), relative to Standard Care (SC), significantly improves biochemically confirmed 7-day point-prevalence smoking abstinence at 18 months post-enrollment. * Secondary Aims * Aim 2: To determine the effects of CCC relative to SC on: cost-effectiveness and 7-day point-prevalence smoking abstinence at 6- and 12-months (biochemically confirmed) post-enrollment. * Aim 3: To compare CCC with SC on cessation treatment use over 18 months of treatment access. Comprehensive Chronic Care (CCC) provides ongoing proactive outreach designed to provide support and information about evidence-based smoking treatment, with access to individually validated treatments that are appropriate for patients who are: 1) unwilling quit but willing to reduce; 2) ready to quit; and 3) recovering from an unsuccessful quit attempt. Standard Care (SC) involves one offer of cessation treatment per year (8 weeks of nicotine patch plus referral to the tobacco quit line).

Interventions

OTHERComprehensive Chronic Care

Those randomized to CCC will receive smoking treatment offers via the following routes: 1) Four Outreach Calls from a Health Counselor at 4, 8, 12, and 14 months post-study enrollment; 2) Four texts and/or mailings (depending on healthcare system preferences) over 14 months. These outreach contacts will offer cessation treatment or reduction treatment.

OTHERStandard Care

one offer of cessation treatment annually

Sponsors

National Cancer Institute (NCI)
CollaboratorNIH
University of Wisconsin, Madison
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* On smoking registry at a participating clinic OR report current smoking at a clinic visit * Smoked cigarettes every day in the past 30 days (with or without other forms of tobacco or nicotine) * Able to participate in informed consent activities (e.g., reports understanding the nature of the study and consent) * Able to speak and read English.

Exclusion criteria

* Activated healthcare power of attorney or cognitive impairment that would preclude informed consent.

Design outcomes

Primary

MeasureTime frameDescription
Number of Participants with biochemically confirmed point-prevalence abstinence at 18 monthsup to 18 monthsGroup differences in abstinence at 18 months will be evaluated using logistic regression.

Secondary

MeasureTime frameDescription
Number of Participants with 7-day point-prevalence abstinence at 6 months6 monthsAt 6 months, participants will be asked whether they have smoked in the past 7 days
Number of Participants with 7-day point-prevalence abstinence at 12 months12 monthsAt 12 months, participants will be asked whether they have smoked in the past 7 days
Group differences in Cessation TreatmentUp to 18 monthsGroup differences in cessation treatment use will be evaluated using logistic regression analysis. Initiating greater than 0 Cessation calls will be coded as binary (use vs. no use).
Total Cost of InterventionUp to 18 monthsIncremental resource costs related to the CCC intervention include Health Counselor/staff time, administration, staff training, recruitment, and medication. Methods recommended by the United States Panel on Cost-Effectiveness in Health and Medicine will be utilized. Costs will be measured from a societal perspective using direct observational data of health system resource use. Cost estimates will be converted to a common year.
Cost Effectiveness measured by incremental cost-effectiveness ratio (ICER)Up to 18 monthsCost per additional person who quits smoking, for the CCC vs. SC. The ICER is calculated as the difference in total costs between CCC and SC divided by the difference in 18-month quit rates.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026